Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | The Biotech Growth Trust PLC (Ordinary Share) | +40.94% |
| NAV | The Biotech Growth Trust PLC (Ordinary Share) | +38.59% |
| Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | +30.53% |
Press releases
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 January 2026
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Investor Presentation via Investor Meet Company
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
More ▼
Key statistics
On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,215.00, -6.54% below its 52-week high of 1,300.00, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 20.72m |
|---|---|
| Market cap | 247.64m GBP |
| Total assets | 301.79m GBP |
| Total expense ratio | -- |
| High | 1,215.00 |
| Low | 1,165.00 |
| Previous close | 1,195.00 |
| Average volume | 48.35k |
|---|---|
| YTD Change | +1.25% |
| Beta | 0.6208 |
| Diluted NAV (est) | 1,284.78 |
| Diluted NAV (last pub) | 1,281.65 |
| Premium/Discount | -5.43% |
| Net Gearing | +12.31% |
Data delayed at least 20 minutes, as of Feb 13 2026 16:35 GMT.
More ▼


